Lanreotide 120mg/0.5ml solution for injection pre-filled syringes
NHS hospitals in England used £57,483,076 of indicative cost of Lanreotide 120mg/0.5ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 9.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lanreotide 120mg/0.5ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lanreotide 120mg/0.5ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Free London Nhs Foundation Trust | £5,222,838 |
| Aintree University Hospital Nhs Ft | £3,596,206 |
| Oxford University Hospitals Nhs Ft | £3,577,466 |
| The Christie Nhs Foundation Trust | £3,564,348 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,076,171 |
| Sheffield Teaching Hospitals Nhs Trust | £2,968,416 |
| University Hpls Coventry & Warwick Trust | £2,531,774 |
| King's College Hpl Nhs Foundation Trust | £1,807,473 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,636,939 |
| Imperial College Healthcare Nhs Trust | £1,515,129 |
The primary-care picture
Lanreotide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Lanreotide medicine page.